Pfizer hikes dividend by 4.2% to $0.43 quarterly
Pfizer Inc. (PFE) has announced a 2.4% increase in its quarterly cash dividend, raising it to $0.43 per share for the first quarter of 2025. This marks 15 consecutive years of increases.
The dividend will be payable on March 7, 2025, to shareholders of record as of the close of business on January 24, 2025. This marks the company’s 345th consecutive quarterly dividend since it began issuing dividends in 1942.
The current dividend yield for Pfizer stands at 2.4%, with the company maintaining a strong position in the pharmaceuticals industry. Pfizer’s market capitalization is $143.8 billion, and its share price is currently $25.37. Despite a -6.5% change in its stock price over the past year, Pfizer remains committed to delivering shareholder value through consistent dividend increases.
Pfizer Inc - Dividend Hikes and Financial Stats
| Year | Dividend Increase |
|---|---|
| 2024 | 2.4% |
| 2023 | 2.4% |
| 2022 | 2.5% |
| 2021 | 2.6% |
| 2020 | 2.6% |
Growth Stats
| Metric | Value |
|---|---|
| 5-Year CAGR | 2.5% |
| 10-Year CAGR | 4.4% |
Key Financial Stats
| Metric | Value |
|---|---|
| Track Record (Years Increased) | 15 |
| Dividend Frequency | Quarterly |
| Data as of | December 12, 2024 |
| Yield | 6.8% |
| Stock Price | $25.37 |
| YTD Total Return | -6.5% |
| Market Cap (in B) | $143.8 |
| Total Dividend Paid (in B) | $9.7 |
Stats provided by DividendHike.com.
Dr. Albert Bourla, Chairman and CEO of Pfizer, stated:
“Our decision to increase our quarterly dividend underscores our strong financial performance, disciplined execution, and our commitment to returning value to our shareholders.”
Pfizer's Dividend History
Pfizer has a long-standing record of reliable dividend payments, which have continued uninterrupted for over 80 years. For more details on Pfizer’s dividend history, visit their official website or explore its performance on Dividend Track Records.
Pfizer Inc. is a biopharmaceutical company with a global portfolio that includes medicines, vaccines and consumer healthcare products. The company runs its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The majority of Pfizer's revenues come from the manufacture and sale of biopharmaceutical products. The company's brands include Advil, Centrum, Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra. Pfizer was incorporated in 1942 and had its IPO in 1944.
